Advertising

The Seattle Times Company

NWjobs | NWautos | NWhomes | NWsource | Free Classifieds | seattletimes.com

The Seattle Times

Biotech


Our network sites seattletimes.com | Advanced

Originally published Tuesday, January 8, 2008 at 12:00 AM

E-mail article     Print view

Seattle Genetics gets shot of cash

Seattle Genetics said Monday it had received a $4 million milestone payment from partner Genentech to begin an early clinical trial on its...

Seattle Times business reporter

SAN FRANCISCO Seattle Genetics said Monday it had received a $4 million milestone payment from partner Genentech to begin an early clinical trial on its lead blood-cancer drug.

The Bothell company now has received between $80 million and $90 million from the San Francisco biotech giant, including $20 million in milestone payments, said Seattle Genetics Chief Executive Clay Siegall.

The deal, which gives Genentech the U.S. and international rights to commercialize the therapy known as SGN-40, was signed in 2007.

"Genentech committed to paying $20 million in milestones in over two years. We've already done that" in one year, Siegall said on the sidelines of the JP Morgan biotech conference in San Francisco.

The cash influx from Genentech last year gave the Seattle area's second-largest biotech company ample cash to finance its operations.

This year, Seattle Genetics plans to ramp up clinical programs for two other experimental therapies that have had promising results.

The company has 200 employees and plans to hire 50 more this year, Siegall said.

While similar arrangements with big partners could represent a great deal of money, Seattle Genetics may opt for a larger degree of independence in its follow-up products.

"We're excited to consider an international deal but we'd like to keep the U.S. [rights]," Siegall said.

Seattle Genetics shares closed Monday at $11.14, up 7.32 percent.

Ángel González: 206-515-5644 or agonzalez@seattletimes.com

Copyright © 2008 The Seattle Times Company

More Biotech headlines...

E-mail article Print view      Share:    Digg     Newsvine

advertising

UPDATE - 01:37 PM
Cell Therapeutics stock resumes trading after week-long halt

Advertising

Video

Medal of Honor
Bruce Crandall and John "Bud" Hawk of Kitsap County say no one "wins" the Medal of Honor. The two recipients of the medal explain they weren't trying to be heroes - just do their duty.

Pelosi answers questions at Swedish Medical Center
Pelosi speaks at Swedish Medical Center
"Pistol" Pete Ryan
Mourners gather at KeyArena for slain officer's memorial
Procession for slain SPD officer
Election Night: Approve R-71
Election Night: Reject R-71
Election Night: Joe Mallahan
Election Night: Mike McGinn

Marketplace

nwautos

2009's most fuel-efficient sedansnew
Choosing a new sedan? Weigh the impact of your choice on your wallet and on the planet.
Post a comment

Open Houses

Find this weekend's open house listings.
Or search by location:

 
Most read
Most commented
Most e-mailed
 
 
Advertising